_id

690daa50ccc777a4e85d08b1

Ticker

AEMD

Name

Aethlon Medical Inc

Exchange

NASDAQ

Address

11555 Sorrento Valley Road, San Diego, CA, United States, 92121

Country

USA

Sector

Healthcare

Industry

Medical Devices

Currency

USD

Website

https://www.aethlonmedical.com

Description

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Last Close

3.4

Volume

20845

Current Price

3.05

Change

-10.294117647058826

Last Updated

2025-11-28T11:53:57.833Z

Image

-

Ipo Date

2001-01-02T00:00:00.000Z

Market Cap

3281280

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.994

Sentiment Sources

1

Rating

3

Target Price

12.375

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

152946

Gross Profit

-152946

Operating Expenses

1356884

Operating Income

-1509830

Interest Expense

-

Pretax Income

-1487100

Net Income

-1487100

Eps

-3.741009727983739

Dividends Per Share

-

Shares Outstanding

761318

Income Tax Expense

-

EBITDA

-1334154

Operating Margin

-

Total Other Income Expense Net

22730

Cash

5853493000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

6253879000

Property Plant Equipment

970488000

Total Assets

7323090000

Payables

570792000

Short Term Debt

324656000

Long Term Debt

-

Total Liabilities

1577113000

Equity

5745977000

Depreciation

152946

Change In Working Capital

-397005

Cash From Operations

-1658717

Capital Expenditures

3

Cash From Investing

-

Cash From Financing

3741122

Net Change In Cash

2088339

PE

0.0206

PB

0.00021100234999200308

ROE

-0.02588071619500043

ROA

-0.02030700155262328

FCF

-1658720

Fcf Percent

-

Piotroski FScore

0

Health Score

41

Deep Value Investing Score

9.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

8

Quality Investing Score

3

Value Investing Score

8

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

152946

Quarters > 0 > income Statement > gross Profit

-152946

Quarters > 0 > income Statement > operating Expenses

1356884

Quarters > 0 > income Statement > operating Income

-1509830

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-1487100

Quarters > 0 > income Statement > net Income

-1487100

Quarters > 0 > income Statement > eps

-3.741009727983739

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

397513

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1334154

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

22730

Quarters > 0 > balance Sheet > cash

5853493000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

6253879000

Quarters > 0 > balance Sheet > property Plant Equipment

970488000

Quarters > 0 > balance Sheet > total Assets

7323090000

Quarters > 0 > balance Sheet > payables

570792000

Quarters > 0 > balance Sheet > short Term Debt

324656000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

1577113000

Quarters > 0 > balance Sheet > equity

5745977000

Quarters > 0 > cash Flow > net Income

-1487100

Quarters > 0 > cash Flow > depreciation

152946

Quarters > 0 > cash Flow > change In Working Capital

-397005

Quarters > 0 > cash Flow > cash From Operations

-1658717

Quarters > 0 > cash Flow > capital Expenditures

3

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

3741122

Quarters > 0 > cash Flow > net Change In Cash

2088339

Quarters > 0 > ratios > PE

-3.741009727983739

Quarters > 0 > ratios > PB

0.00021100234999200308

Quarters > 0 > ratios > ROE

-0.02588071619500043

Quarters > 0 > ratios > ROA

-0.02030700155262328

Quarters > 0 > ratios > FCF

-1658720

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

41

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

154907

Quarters > 1 > income Statement > gross Profit

-154907

Quarters > 1 > income Statement > operating Expenses

1637483

Quarters > 1 > income Statement > operating Income

-1792390

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-1761858

Quarters > 1 > income Statement > net Income

-1761858

Quarters > 1 > income Statement > eps

-8.485116137949634

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

207641

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1606947

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

30532

Quarters > 1 > balance Sheet > cash

3765154

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

4050858

Quarters > 1 > balance Sheet > property Plant Equipment

1123296

Quarters > 1 > balance Sheet > total Assets

5306002

Quarters > 1 > balance Sheet > payables

571495

Quarters > 1 > balance Sheet > short Term Debt

431527

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

1882489

Quarters > 1 > balance Sheet > equity

3423513

Quarters > 1 > cash Flow > net Income

-1761858000

Quarters > 1 > cash Flow > depreciation

82637000

Quarters > 1 > cash Flow > change In Working Capital

-180428

Quarters > 1 > cash Flow > cash From Operations

-1714937000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-5357000

Quarters > 1 > cash Flow > net Change In Cash

-1735790000

Quarters > 1 > ratios > PE

-8.485116137949634

Quarters > 1 > ratios > PB

0.1849868979612462

Quarters > 1 > ratios > ROE

-51.463452891810256

Quarters > 1 > ratios > ROA

-33.205000676592284

Quarters > 1 > ratios > FCF

-1714937000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

37

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

172120

Quarters > 2 > income Statement > cost Of Revenue

83864

Quarters > 2 > income Statement > gross Profit

-83864

Quarters > 2 > income Statement > operating Expenses

1920099

Quarters > 2 > income Statement > operating Income

-2003963

Quarters > 2 > income Statement > interest Expense

10109

Quarters > 2 > income Statement > pretax Income

-6254893

Quarters > 2 > income Statement > net Income

-6254893

Quarters > 2 > income Statement > eps

-40.06978219090327

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

156100

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-6160925

Quarters > 2 > income Statement > operating Margin

-1164.2824773413897

Quarters > 2 > income Statement > total Other Income Expense Net

-4250930

Quarters > 2 > balance Sheet > cash

5501261

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

5949800

Quarters > 2 > balance Sheet > property Plant Equipment

1278066

Quarters > 2 > balance Sheet > total Assets

7359534

Quarters > 2 > balance Sheet > payables

534524

Quarters > 2 > balance Sheet > short Term Debt

313033

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

2236004

Quarters > 2 > balance Sheet > equity

5123530

Quarters > 2 > cash Flow > net Income

-6254893

Quarters > 2 > cash Flow > depreciation

83864

Quarters > 2 > cash Flow > change In Working Capital

-258393

Quarters > 2 > cash Flow > cash From Operations

-1672649

Quarters > 2 > cash Flow > capital Expenditures

2192

Quarters > 2 > cash Flow > cash From Investing

2192

Quarters > 2 > cash Flow > cash From Financing

2359060

Quarters > 2 > cash Flow > net Change In Cash

686181

Quarters > 2 > ratios > PE

-40.06978219090327

Quarters > 2 > ratios > PB

0.09292519024969113

Quarters > 2 > ratios > ROE

-122.08170929027449

Quarters > 2 > ratios > ROA

-84.99034042101036

Quarters > 2 > ratios > FCF

-1674841

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-9.730658842667905

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

83808

Quarters > 3 > income Statement > gross Profit

-83808

Quarters > 3 > income Statement > operating Expenses

1814747

Quarters > 3 > income Statement > operating Income

-1814747

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-1754783

Quarters > 3 > income Statement > net Income

-1754783

Quarters > 3 > income Statement > eps

-8.614884236985253

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

203692

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-1730939

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

59964

Quarters > 3 > balance Sheet > cash

4825387

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

4968407

Quarters > 3 > balance Sheet > property Plant Equipment

1435453

Quarters > 3 > balance Sheet > total Assets

6525359

Quarters > 3 > balance Sheet > payables

610909

Quarters > 3 > balance Sheet > short Term Debt

307326

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

2191193

Quarters > 3 > balance Sheet > equity

4334166

Quarters > 3 > cash Flow > net Income

-1754782

Quarters > 3 > cash Flow > depreciation

83808

Quarters > 3 > cash Flow > change In Working Capital

-500464

Quarters > 3 > cash Flow > cash From Operations

-2010788

Quarters > 3 > cash Flow > capital Expenditures

2192

Quarters > 3 > cash Flow > cash From Investing

-2192

Quarters > 3 > cash Flow > cash From Financing

-7073

Quarters > 3 > cash Flow > net Change In Cash

-2033688

Quarters > 3 > ratios > PE

-8.614884236985253

Quarters > 3 > ratios > PB

0.14334028738170157

Quarters > 3 > ratios > ROE

-40.48721253408383

Quarters > 3 > ratios > ROA

-26.89174649241521

Quarters > 3 > ratios > FCF

-2012980

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

37

Valuation > metrics > PE

0.0206

Valuation > metrics > PB

0.00021100234999200308

Valuation > final Score

90

Valuation > verdict

99.9% Undervalued

Profitability > metrics > ROE

-0.02588071619500043

Profitability > metrics > ROA

-0.023778841899563457

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.27447255706035717

Risk > metrics > Interest Coverage

-9.871654047833877

Risk > final Score

21

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.984078360775835

Liquidity > metrics > Quick Ratio

6.984078360775835

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

0

Prev Profitabilities > 2

15

Prev Risks > 0

2

Prev Risks > 1

-733

Prev Risks > 2

-256

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:23:04.548Z